Olga Grishina

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Jürgen Finke, Wolfgang Bethge, Claudia Schmoor et al. · The Lancet Oncology · 2009 · 705 citations

Unrelated Donors, Graft-versus-host Disease, Transplantation +12

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

Gèrard Socié, Claudia Schmoor, Wolfgang Bethge et al. · Blood · 2011 · 302 citations · Full text

Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial

Jürgen Finke, Claudia Schmoor, Wolfgang Bethge et al. · The Lancet Haematology · 2017 · 109 citations

Haemopoietic Cell Transplantation, Unrelated Donors, Transplantation +12

Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial

Michael Lübbert, Olga Grishina, Claudia Schmoor et al. · Journal of Clinical Oncology · 2019 · 88 citations

High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)

Elisabeth Schorb, Jürgen Finke, Andrés J.M. Ferreri et al. · BMC Cancer · 2016 · 68 citations · Full text